Journal of Multiple Sclerosis
ISSN - 2376-0389NLM - 101654564
Efrat Saraf Lavi
Tanzania
Case Report
Natalizumab Associated PML in a Multiple Sclerosis Patient: Excellent Response to Minimal Intervention
Author(s): Silvia R. Delgado, Efrat Saraf Lavi, Yesica A. Campos, Melissa Ortega, Kottil Rammohan and William A. SheremataSilvia R. Delgado, Efrat Saraf Lavi, Yesica A. Campos, Melissa Ortega, Kottil Rammohan and William A. Sheremata
We present a case of a woman with natalizumab associated progressive multifocal leukoencephalopathy (PML) who developed an immune reconstitution inflammatory syndrome (IRIS) 9 weeks after natalizumab withdrawal. She responded well to a small dose of steroids intravenously, without plasma exchange, and has returned to her baseline status within one year of her initial symptoms and MRI abnormality... View More»
DOI: 10.4172/jmso.1000119
